Ando focus is on discovery and development of drug/ vaccine candidates. The company was established in 2008, is located in Denmark and owned by Dr. Anke Domdey.
Anke is an expert in early drug/ vaccine development, regulatory strategic planning and implementation. Anke has experience and know-how from 20+ years in different managerial roles and hands-on project leadership in global R&D of Biotech & Pharma and from 10+ years in various consulting roles.
Anke has worked across several therapeutic areas among them oncology, autoimmune diseases, CNS, cardiovascular diseases, infectious diseases and has dealt with small molecules, peptides, biologics and ATMPs. Anke is assessor of EUREKA Eurostars and Innovation Denmark funding applications.
Anke operates within a large network of consultants & service providers allowing her to source specific expertise and resources should these be required.
Anke is very analytical, has a structured approach, a sense of urgency and never loses the big picture while focusing on details at the same time. Anke is very integrative, inspiring and an excellent communicator.